309 related articles for article (PubMed ID: 18854695)
21. Update on thyroid eye disease.
Stemberger K; Kahaly GJ; Pitz S
Compr Ophthalmol Update; 2006; 7(6):287-98. PubMed ID: 17244445
[TBL] [Abstract][Full Text] [Related]
22. Low dose orbital radiotherapy for thyroid eye disease.
Li Yim JF; Sandinha T; Kerr JM; Ritchie D; Kemp EG
Orbit; 2011 Dec; 30(6):269-74. PubMed ID: 22132844
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy for Active Thyroid Eye Disease.
Godfrey KJ; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S98-S104. PubMed ID: 29771752
[TBL] [Abstract][Full Text] [Related]
24. Current trends in the management of thyroid eye disease.
Rao R; MacIntosh PW; Yoon MK; Lefebvre DR
Curr Opin Ophthalmol; 2015 Nov; 26(6):484-90. PubMed ID: 26397888
[TBL] [Abstract][Full Text] [Related]
25. Thyroid eye disease.
Cockerham KP; Chan SS
Neurol Clin; 2010 Aug; 28(3):729-55. PubMed ID: 20637998
[TBL] [Abstract][Full Text] [Related]
26. Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.
Volpe NJ; Sbarbaro JA; Gendron Livingston K; Galetta SL; Liu GT; Balcer LJ
Am J Ophthalmol; 2006 Jul; 142(1):75-81. PubMed ID: 16815253
[TBL] [Abstract][Full Text] [Related]
27. Grading Severity and Activity in Thyroid Eye Disease.
Dolman PJ
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S34-S40. PubMed ID: 29952931
[TBL] [Abstract][Full Text] [Related]
28. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
[TBL] [Abstract][Full Text] [Related]
29. Thyroid eye disease: therapy in the active phase.
Bhatti MT; Dutton JJ
J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102
[TBL] [Abstract][Full Text] [Related]
30. [Ocular myopathies and autoimmunity].
Eckstein A; Esser J
Klin Monbl Augenheilkd; 2014 Sep; 231(9):e47, e49-65; quiz e66-7. PubMed ID: 25116065
[No Abstract] [Full Text] [Related]
31. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease.
Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ
Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States.
Wang Y; Padnick-Silver L; Francis-Sedlak M; Holt RJ; Foley C; Douglas RS
Endocr Pract; 2022 Sep; 28(9):842-846. PubMed ID: 35714862
[TBL] [Abstract][Full Text] [Related]
33. Update on the clinical assessment and management of thyroid eye disease.
Roos JCP; Murthy R
Curr Opin Ophthalmol; 2019 Sep; 30(5):401-406. PubMed ID: 31313753
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity and responsiveness of the patient-reported TED-QOL to rehabilitative surgery in thyroid eye disease.
Fayers T; Fayers PM; Dolman PJ
Orbit; 2016 Dec; 35(6):328-334. PubMed ID: 27599688
[TBL] [Abstract][Full Text] [Related]
35. Thyroid Eye Disease With Significant Levator Involvement and Ptosis: A Case Report.
Scruggs RT; Black EH
Ophthalmic Plast Reconstr Surg; 2015; 31(6):e153-4. PubMed ID: 24896772
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
[TBL] [Abstract][Full Text] [Related]
37. [Graves' ophthalmopathy].
Hiromatsu Y
Nihon Rinsho; 2006 May; Suppl 1():307-10. PubMed ID: 16776151
[No Abstract] [Full Text] [Related]
38. Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease.
Tan NYQ; Leong YY; Lang SS; Htoon ZM; Young SM; Sundar G
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2527-2533. PubMed ID: 28492870
[TBL] [Abstract][Full Text] [Related]
39. A Chinese survey of clinical practice on the management of thyroid eye disease.
Chen J; Li C; Teng W; Shan Z; Jin J; Wei Y; Sun J; Li Y; Zhou H
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642583
[TBL] [Abstract][Full Text] [Related]
40. Advances in steroid sparing medical management of active thyroid eye disease.
Liou VD; Yoon MK
Semin Ophthalmol; 2020 May; 35(4):216-223. PubMed ID: 32684074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
